WSJ
29 Jul 2026, 10:40 UTC · 13w ago
Humana Cuts Outlook Again on Lower Medicare Ratings
Impact · against what's priced in
Humana's stock faces downward pressure following a reduction in full-year earnings guidance. The outlook cut is driven by structural revenue headwinds resulting from lower 2026 Medicare Advantage Star Ratings.
- HUM−0.70
No priced-in read yet
- In context
The company has reduced its full-year earnings outlook due to lower Medicare Advantage Star Ratings for 2026, which reduces government bonus payments.
Read from the article alone
Top 1 mover · tap to explore
